The expansion will focus on physician-led neurovascular technologies and medical device manufacturing across Middle Eastern and African markets.
LAKE FOREST, California, Sept. 9, 2026 — David Ferrera, CEO of RC Medical, has announced the formation of new medical device ventures in the Middle East and Africa, expanding his physician-led venture studio model into the MEA region.
The new initiatives will focus on neurovascular intervention technologies and medical device manufacturing, marking a new phase in Ferrera’s nearly three decades of experience in medical device development.
The expansion builds on Ferrera’s work in neurovascular and interventional medicine, where he has helped establish and develop multiple medical device companies. Several of those ventures were later acquired by major industry companies, including Johnson & Johnson, Covidien, and Balt of France.
The newly announced MEA initiatives are intended to combine physician collaboration, engineering, product development, and regional manufacturing capabilities to support the development of medical technologies suited to local clinical needs.
Expansion Focuses on Neurovascular Technology and Manufacturing
The new ventures will focus on two primary areas: neurovascular intervention products and medical device manufacturing.
The neurovascular initiatives will follow a development model similar to the one used through RC Medical in the United States. This approach involves working with physicians to identify clinical challenges during interventional procedures and then evaluating potential device solutions through engineering, product development, testing, and commercialization processes.
Physician involvement is central to the model because clinicians can provide direct insight into procedural challenges and unmet needs. These insights can then guide engineering teams as they evaluate whether a new product concept can provide a practical solution.
The expansion into the Middle East and Africa is expected to extend this collaborative approach by supporting relationships with physicians, healthcare professionals, engineers, and other regional stakeholders.
Medical device manufacturing will form the second major area of the expansion. Establishing manufacturing capabilities closer to target markets may help improve supply-chain efficiency, support regional product development, and allow companies to respond more effectively to local healthcare requirements.
Ferrera’s background in plastics engineering and medical device development provides technical experience relevant to this part of the expansion.
Building on Nearly Three Decades of Medical Device Experience
The announcement follows a long history of involvement in neurovascular and interventional medical device companies.
Ferrera co-founded Micrus Endovascular in 1997. The company developed technologies used in the treatment of cerebral aneurysms and was acquired by Johnson & Johnson in 2010.
He later helped build MindFrame Inc., contributing to the development of the company’s acute stroke mechanical thrombectomy product line. MindFrame was acquired by Covidien in 2012.
In 2011, Ferrera co-founded Blockade Medical and served as President and Chief Technology Officer. The company was acquired by Balt Extrusion of France in 2016. Following the acquisition, Ferrera served as Chief Technology Officer of Balt Global, adding international medical device operations and distribution experience to his background.
Since 2012, Ferrera has operated through RC Medical, a medical device venture studio based in Lake Forest, California. The company works with physicians to identify unmet clinical needs and develop technologies for interventional radiology and related medical fields.
RC Medical’s model combines clinical input, engineering, product development, funding, and commercialization within a venture-building structure. This allows individual businesses or product programs to be developed around specific medical problems identified in clinical practice.
Physician-Led Development Model Expands Into MEA Markets
The new Middle East and Africa ventures are expected to follow the same physician-led framework used in Ferrera’s U.S.-based medical device activities.
The process begins with identifying clinical challenges and determining whether those problems can be addressed through new medical technologies. Product concepts can then move through design, engineering, testing, regulatory planning, and commercialization based on their technical and clinical potential.
This structured approach is intended to reduce development uncertainty while keeping product design focused on real-world medical needs.
Ferrera has also explored these principles in his 2021 book, Innovation in Translation – How Big Ideas Really Happen, published by Advantage-Forbes. The book examines medical innovation, structured problem-solving, teamwork, leadership, and the process of moving ideas toward practical products.
The MEA expansion extends those principles into new healthcare markets while creating opportunities for regional collaboration and medical device development.
International Expansion Marks a New Phase for RC Medical
Ferrera began his medical device career at Boston Scientific in 1992 after earning a degree in plastics engineering from the University of Lowell, now UMass Lowell.
Over the following decades, he became involved in the creation and development of several medical technology businesses, with a particular focus on neurovascular and interventional products.
The newly announced ventures represent an expansion of that work beyond the United States and establish an additional international focus for Ferrera’s venture-building activities.
The initiative is centered on creating and developing companies focused on neurovascular technology, physician-led innovation, and medical device manufacturing within Middle Eastern and African markets.
Additional information about David Ferrera and his medical device ventures is available here.
About David Ferrera
David Ferrera is CEO of RC Medical, a medical device venture studio based in Lake Forest, California. He is an engineer, entrepreneur, inventor, and advisor with nearly 30 years of experience in medical device development.
He has co-founded multiple medical device companies, including Micrus Endovascular, MindFrame Inc., and Blockade Medical. Ferrera is also the author of Innovation in Translation – How Big Ideas Really Happen, published by Advantage-Forbes in 2021.
Media Contact
Email: [email protected]
